Probiotic Formulations: Application and Status as Pharmaceuticals-A Review

Probiotics and Antimicrobial Proteins
V Sreeja, Jashbhai B Prajapati

Abstract

The use of probiotics is a new way to control and treat infections in this modern era. Application of beneficial bacteria to protect against detrimental bacteria in the gastrointestinal tract and thus reap a positive health benefit is the basis of probiotic therapy. Probiotics have a long global history of traditional use. They are normally consumed through fermented foods and are currently sold mostly as ingredients in foods or nutritional supplements. They are also supplied as pharma products. Recent research has highlighted the probiotic potential in the treatment or prevention of disease conditions, maintenance of health, improving immunity and in the reduction in the risk of future diseases. But their position in the pharmaceutical industry is still not very clear. Clinical practitioners use probiotic pharma products mostly as supplements. Their status as drugs is still unclear. This review is aimed to analyze probiotics as pharmaceuticals, their current status as dietary supplements and drugs, existing probiotic preparations and future research needs.

References

Apr 1, 1991·Gut·R Fuller
Aug 1, 1997·The American Journal of Clinical Nutrition·E J SchiffrinA Donnet-Hughes
Nov 5, 1999·The Journal of Pediatrics·J A VanderhoofR J Young
Nov 9, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E IsolauriS Salminen
Dec 19, 2000·International Journal of Antimicrobial Agents·B Mombelli, M R Gismondo
Feb 7, 2001·The American Journal of Clinical Nutrition·P R MarteauJ Schrezenmeir
Jun 8, 2001·The American Journal of Clinical Nutrition·J M Saavedra
Jul 14, 2001·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·G W Elmer
Jan 23, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Indu Pal KaurAmarpreet Saini
Mar 7, 2002·International Journal of Pharmaceutics·Libo YangJoseph A Fix
Sep 12, 2002·Cellular and Molecular Life Sciences : CMLS·M Heyman, S Ménard
May 2, 2003·Nutrition Reviews·Mary Ellen Sanders
Sep 26, 2003·Best Practice & Research. Clinical Gastroenterology·Philippe Marteau, Fergus Shanahan
Jan 30, 2004·The American Journal of Clinical Nutrition·Jose M SaavedraRobert H Yolken
Apr 13, 2004·Journal of Pediatric Gastroenterology and Nutrition·Jean-Pierre ChouraquiMarie-Claire Fichot
Sep 10, 2004·Postgraduate Medical Journal·H S Gill, F Guarner
Dec 4, 2004·European Journal of Nutrition·Michael de VreseJürgen Schrezenmeir
Sep 28, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·H J KimA R Zinsmeister
Nov 9, 2005·Environmental Health : a Global Access Science Source·Py TubeliusAnders Zachrisson
May 16, 2006·Journal of Applied Microbiology·S ParvezH-Y Kim
Jun 10, 2006·The American Journal of Clinical Nutrition·Robert J BoyleMimi L K Tang
Feb 15, 2007·Travel Medicine and Infectious Disease·Lynne V McFarland
Feb 22, 2007·The Journal of Nutrition·Drahoslava Lesbros-PantoflickovaAndré L Blum
May 11, 2007·Journal of Paediatrics and Child Health·Daniel A LembergAndrew S Day
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Freddie Ann Hoffman
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maija Saxelin
Apr 15, 2008·Clinical Therapeutics·Robert Barrons, Dan Tassone
Jun 11, 2008·Journal of Clinical Gastroenterology·Shira Idit DoronSherwood L Gorbach
Aug 15, 2008·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ljubomir PetricevicHerbert Kiss
Oct 1, 2008·Journal of Clinical Gastroenterology·Anand Prakash DubeyGiuseppe Famularo
Aug 27, 2009·Biologics : Targets & Therapy·Satya Prakash, Aleksandra Malgorzata Urbanska
Nov 10, 2009·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Iva HojsakSanja Kolacek
Sep 25, 2010·The British Journal of Nutrition·Teemu TaipaleEva Söderling

❮ Previous
Next ❯

Citations

Sep 6, 2018·Food & Function·Monique Santos do CarmoValério Monteiro-Neto
Oct 26, 2018·The Journal of Microbiology·Eun-Sook LeeSo-Young Lee
Jun 3, 2020·Future Microbiology·Mohsin Khurshid, Muhammad Sh Akash
Jul 12, 2019·Scientific Reports·Hary RazafindralamboChristophe Blecker
Oct 17, 2019·Probiotics and Antimicrobial Proteins·Chukwuemeka Calistus OkoloIfeanyi James Eze
Jan 24, 2021·Journal of Nephrology·Kullaya TakkavatakarnPaweena Susantitaphong
Aug 7, 2021·Frontiers in Microbiology·Diletta MazzantiniEmilia Ghelardi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Gastroenterology
Fang Yan, David Brent Polk
The Journal of Perinatal & Neonatal Nursing
Andi L Shane
World Journal of Clinical Oncology
Felix AragónAlejandra de Moreno de LeBlanc
© 2022 Meta ULC. All rights reserved